|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013798,
umls-concept:C0019134,
umls-concept:C0022877,
umls-concept:C0028910,
umls-concept:C0030705,
umls-concept:C0205393,
umls-concept:C0206460,
umls-concept:C0392747,
umls-concept:C0441471,
umls-concept:C0444669,
umls-concept:C0449450,
umls-concept:C0814225,
umls-concept:C0948089,
umls-concept:C1522318
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-3-29
|
|
pubmed:abstractText |
We undertook a prospective electrocardiogram (ECG) substudy in the ESSENCE trial and hypothesized that patient subgroups with ST-segment deviation would experience greater benefit from enoxaparin, as compared with unfractionated heparin (UFH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
151
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
791-7
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16569535-Angina, Unstable,
pubmed-meshheading:16569535-Electrocardiography,
pubmed-meshheading:16569535-Enoxaparin,
pubmed-meshheading:16569535-Female,
pubmed-meshheading:16569535-Fibrinolytic Agents,
pubmed-meshheading:16569535-Heparin,
pubmed-meshheading:16569535-Humans,
pubmed-meshheading:16569535-Male,
pubmed-meshheading:16569535-Middle Aged,
pubmed-meshheading:16569535-Multicenter Studies as Topic,
pubmed-meshheading:16569535-Myocardial Infarction,
pubmed-meshheading:16569535-Prognosis,
pubmed-meshheading:16569535-Proportional Hazards Models,
pubmed-meshheading:16569535-Prospective Studies,
pubmed-meshheading:16569535-Randomized Controlled Trials as Topic,
pubmed-meshheading:16569535-Survival Analysis,
pubmed-meshheading:16569535-Syndrome,
pubmed-meshheading:16569535-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
|
|
pubmed:affiliation |
Division of Cardiology, Canadian Heart Research Centre, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. goodmans@smh.toronto.on.ca
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
